KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Stereotaxis (STXS) EBIT (2016 - 2025)

Stereotaxis (STXS) has disclosed EBIT for 16 consecutive years, with -$6.6 million as the latest value for Q3 2025.

  • On a quarterly basis, EBIT fell 3.34% to -$6.6 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$24.1 million, a 7.47% decrease, with the full-year FY2024 number at -$24.7 million, down 13.28% from a year prior.
  • EBIT was -$6.6 million for Q3 2025 at Stereotaxis, down from -$4.0 million in the prior quarter.
  • In the past five years, EBIT ranged from a high of -$1.5 million in Q1 2021 to a low of -$7.6 million in Q4 2024.
  • A 5-year average of -$5.0 million and a median of -$5.2 million in 2022 define the central range for EBIT.
  • Peak YoY movement for EBIT: tumbled 195.57% in 2021, then surged 33.95% in 2025.
  • Stereotaxis' EBIT stood at -$3.3 million in 2021, then plummeted by 33.05% to -$4.5 million in 2022, then dropped by 19.03% to -$5.3 million in 2023, then tumbled by 43.8% to -$7.6 million in 2024, then increased by 14.03% to -$6.6 million in 2025.
  • Per Business Quant, the three most recent readings for STXS's EBIT are -$6.6 million (Q3 2025), -$4.0 million (Q2 2025), and -$5.9 million (Q1 2025).